Future-Proofing Healthcare: Balancing Innovation, Cost and Accessibility
Future-Proofing Healthcare: Balancing Innovation, Cost and Accessibility
Co-organised by the HKU School of Public Health (HTA Hub) and Our Hong Kong Foundation, “Future-Proofing Healthcare: Balancing Innovation, Cost and Accessibility” brings together key healthcare leaders, policymakers, and academics to explore value assessment frameworks for innovative drugs, particularly for cancer and rare diseases, ensuring groundbreaking treatments remain cost-effective and accessible.
Key Focus Areas:
Building Value Frameworks: Key factors for a patient-centric drug assessment system and how to implement it effectively in Hong Kong.
Targeting High-Impact Areas: Tailored assessment models for cancer and rare diseases to optimise resources where innovative treatments are needed most.
Join key stakeholders at the forefront of policy transformation to shape the future of Hong Kong’s healthcare ecosystem.
Co-organised by the HKU School of Public Health (HTA Hub) and Our Hong Kong Foundation, “Future-Proofing Healthcare: Balancing Innovation, Cost and Accessibility” brings together key healthcare leaders, policymakers, and academics to explore value assessment frameworks for innovative drugs, particularly for cancer and rare diseases, ensuring groundbreaking treatments remain cost-effective and accessible.
Key Focus Areas:
Building Value Frameworks: Key factors for a patient-centric drug assessment system and how to implement it effectively in Hong Kong.
Targeting High-Impact Areas: Tailored assessment models for cancer and rare diseases to optimise resources where innovative treatments are needed most.
Join key stakeholders at the forefront of policy transformation to shape the future of Hong Kong’s healthcare ecosystem.
